Apexon Precision Dynamics CEO Noah Kim participated in a panel discussion at a recent industry conference focused on the future of diagnostic technologies. The session included perspectives from several companies in the biotech and therapeutics sector, with topics ranging from data integration to patient engagement strategies. Kim emphasized the importance of collaboration between research platforms and clinical care systems in improving diagnostic accuracy.